HerbParlor
Turmeric (Curcuma longa)Moderate evidence

Turmeric

Curcuma longa

Overview

At a glance

Turmeric is the rhizome of Curcuma longa. Human research is most developed around knee osteoarthritis, but turmeric powder, turmeric extracts, concentrated curcuminoids and bioavailability-enhanced curcumin are not interchangeable interventions.

Key takeaway

The evidence for knee osteoarthritis is promising but heterogeneous. The preparation matters: turmeric powder, turmeric extract, concentrated curcuminoids and enhanced-bioavailability curcumin can represent materially different interventions.

Common uses studied

Culinary useTraditional digestive and inflammatory usesKnee osteoarthritis researchOther marketed uses where evidence remains limited or preliminary

Start here

What are you trying to figure out?

Pick the question closest to yours. Each card jumps to the relevant part of this profile or an existing HerbParlor tool — no sponsored rankings, no hidden ordering.

Identity

What is this herb?

Family

Zingiberaceae

Species

Curcuma longa

Common names

TurmericTurmeric rootIndian saffron

Plant parts used

Rhizome

Geographic context

Native to South Asia and widely cultivated in India and other tropical region.

Identification notes

Turmeric is the rhizome of Curcuma longa. Curcumin is a major constituent of turmeric, not the botanical itself. Turmeric material and purified or concentrated curcuminoid preparations should therefore not be treated as equivalent.

Background

Traditional context

Traditions

Ayurvedic medicineTraditional Chinese medicineIslamic traditional medicineThai traditional medicine

Historical uses

Digestive complaintsInflammatory conditionsSkin-related usesOther traditional applications

Traditional use provides historical context but does not by itself establish clinical efficacy. Modern clinical studies frequently evaluate extracts or curcuminoid preparations rather than ordinary culinary turmeric.

Preparations

Forms & preparations

Forms

Culinary turmericWhole turmeric powderTurmeric extractCurcuminoid extractConcentrated curcuminBioavailability-enhanced curcumin

Preparation methods

Whole-rhizome powderExtracts containing concentrated constituentsCurcuminoid-enriched extractsFormulations designed to increase curcumin exposure

What changes between forms

  • Turmeric powder is not equivalent to concentrated curcumin extract.
  • Extracts can differ substantially in curcuminoid content, composition, dose and formulation.
  • Bioavailability-enhancing technologies can materially change exposure.
  • Piperine and other delivery technologies can change pharmacokinetics and how a product should be interpreted against clinical research.

Clinical trials use multiple turmeric and curcuminoid preparations. Evidence should be mapped to the actual intervention studied rather than transferred automatically across every turmeric or curcumin product.

Research

Research Explorer

Each question summarizes what human research has examined, how it was studied, and the main limitations — not a treatment recommendation.

Can turmeric or curcumin reduce knee osteoarthritis pain?

Population

Adults with knee osteoarthritis in randomized clinical trials and meta-analyses.

Intervention

Various turmeric and curcuminoid preparations, including turmeric powder, extracts and bioavailability-enhanced curcumin.

Comparator

Placebo, control, or sometimes a non-steroidal anti-inflammatory comparator.

Outcomes studied

Pain scoresVisual analog scale painWOMAC pain subscale

Evidence assessment

Promising human evidence but heterogeneous and not definitive.

Limitations

  • Different preparations and formulations
  • Different doses and durations
  • Variable study quality and risk of bias
  • Heterogeneity across pooled analyses

Can turmeric or curcumin improve knee osteoarthritis physical function?

Population

Adults with knee osteoarthritis in randomized clinical trials and meta-analyses.

Intervention

Various turmeric and curcuminoid preparations.

Comparator

Placebo, control, or a non-steroidal anti-inflammatory comparator.

Outcomes studied

WOMAC function subscalePhysical function scoresDisability-related outcomes

Evidence assessment

Promising signal with meaningful uncertainty.

Limitations

  • Different preparations and formulations
  • Different outcome measures
  • Heterogeneity across pooled analyses
  • Limited long-term data

Does the turmeric or curcumin formulation matter?

Population

Adults across turmeric and curcumin clinical trials, compared indirectly in network meta-analysis.

Intervention

Different turmeric and curcumin formulations, including bioavailability-enhanced preparations.

Comparator

Placebo or other formulations, compared indirectly.

Outcomes studied

Knee osteoarthritis pain and function outcomesComparative effectiveness between formulations

Evidence assessment

Formulation matters, but evidence does not establish one universally superior formulation; 2025 network meta-analysis certainty is low.

Limitations

  • Indirect comparisons rather than head-to-head trials
  • Low certainty of network meta-analysis estimates
  • Preparation and dose heterogeneity
  • Lack of direct product-to-product comparisons

Can turmeric or curcumin help with nonalcoholic fatty liver disease?

Population

Adults with nonalcoholic fatty liver disease studied in clinical trials.

Intervention

Turmeric or curcuminoid preparations.

Comparator

Placebo or control.

Outcomes studied

Liver enzyme measuresImaging-based liver fat estimatesMetabolic markers

Evidence assessment

Preliminary and insufficient.

Limitations

  • Small evidence base
  • Preparation variability
  • Limited long-term data
  • Uncertain clinical significance

Can turmeric or curcumin reduce oral mucositis?

Population

People at risk of oral mucositis, including patients receiving cancer treatment, studied in clinical trials.

Intervention

Turmeric or curcumin preparations, often as a mouthwash or oral formulation.

Comparator

Placebo, control, or standard care.

Outcomes studied

Oral mucositis severityIncidence of mucositisPain and oral function

Evidence assessment

Preliminary and not established.

Limitations

  • Small number of trials
  • Preparation and route variability
  • Heterogeneous populations
  • Limited replication

Do broad marketed health claims for turmeric and curcumin hold up?

Population

Adults across a range of marketed inflammatory, metabolic and general health claims.

Intervention

Various turmeric and curcumin preparations.

Comparator

Placebo or control.

Outcomes studied

Broadly marketed inflammatory, metabolic and general health outcomes

Evidence assessment

Insufficient evidence for broad claims.

Limitations

  • Many marketed uses lack direct clinical evidence
  • Preparation variability
  • Small or short-term studies
  • Results should not be generalized across preparations

Latest evidence

Recently published research

Searching Europe PMC…

Looking for recent publications…

These publications are automatically discovered from Europe PMC. They have not necessarily been independently reviewed by HerbParlor and are not automatically incorporated into the evidence assessment.

Evidence

Evidence

Promising for some knee osteoarthritis outcomes, but preparation-dependent and not yet definitive.

Evidence tier

Moderate

Confidence

Moderate for the existence of a human knee-osteoarthritis signal; lower for identifying a universally superior formulation or applying evidence from one curcumin preparation to all turmeric products.

Last evidence review

2026-09-15

Where the evidence is strongest

Knee osteoarthritis painKnee osteoarthritis physical function

How to interpret this

Turmeric and curcumin have a meaningful human research signal for some knee osteoarthritis outcomes, but the evidence is heterogeneous and formulation-dependent. A product's turmeric or curcumin amount alone is not enough to determine how closely it resembles the research intervention.

Automatic evidence update

Since the last editorial review

Checking Europe PMC…
Checking evidence

Checking for publications published since the last editorial evidence review…

This automatic update detects newly published literature; it does not replace HerbParlor's editorial evidence assessment. Review status is an automatic triage signal. Curated HerbParlor evidence is unchanged until editorial review.

Boundaries

What the evidence does NOT establish

Areas with limited evidence

  • Nonalcoholic fatty liver disease
  • Oral mucositis
  • Other broadly marketed inflammatory or metabolic uses

Evidence gaps

  • Optimal preparation and formulation
  • Clinically meaningful differences between bioavailability technologies
  • Long-term efficacy
  • Long-term safety
  • Head-to-head product comparisons
  • Which patients respond best
  • How closely individual commercial products match research interventions

Common misconceptions

  • All turmeric supplements are equivalent.
  • Turmeric powder is equivalent to concentrated curcumin.
  • All curcumin extracts are equivalent.
  • Higher bioavailability automatically means better clinical outcomes.
  • Piperine-containing products are automatically superior.
  • Turmeric treats inflammation generally.
  • Turmeric prevents or treats every condition for which it is marketed.
  • Short-term knee osteoarthritis studies establish long-term benefit.
  • A larger milligram number necessarily means a stronger or better product.
  • Evidence for one named curcumin formulation automatically applies to every curcumin product.

Safety

Safety & interactions

General considerations

  • Conventional oral turmeric or curcumin appears reasonably well tolerated for recommended amounts over short periods, but long-term safety is not established.
  • Culinary exposure is not equivalent to concentrated supplement exposure.

Contraindications

  • Pregnancy caution
  • Uncertain breastfeeding safety
  • Bile duct obstruction or gallstone-related caution

Pregnancy & nursing

Medication interactions to be aware of

Anticoagulant and antiplatelet medicationsBlood-thinning medicationsMedications metabolized by the liverDiabetes medicationsAcid-reducing medications

Condition considerations

  • Liver disease or previous supplement-associated liver injury
  • Gallbladder or bile-duct conditions
  • Bleeding disorders
  • Upcoming surgery

Reported adverse effects

  • Nausea
  • Vomiting
  • Reflux
  • Stomach upset
  • Diarrhea
  • Constipation
  • Rare clinically important liver injury, particularly reported with some highly bioavailable formulations

Duration

Talk to a healthcare professional if any apply

  • Pregnancy
  • Breastfeeding
  • Liver disease
  • Previous supplement-associated liver injury
  • Concentrated or bioavailability-enhanced curcumin use
  • Multiple medications
  • Liver-injury symptoms

Products

What changes between products?

Form differences

  • Turmeric powder is not equivalent to concentrated curcumin extract.
  • Extracts can differ substantially in curcuminoid content, composition, dose and formulation.
  • Bioavailability-enhancing technologies can materially change exposure.
  • Piperine and other delivery technologies can change pharmacokinetics and how a product should be interpreted against clinical research.

Form considerations

  • Whole turmeric powder, turmeric extracts, concentrated curcuminoids and bioavailability-enhanced curcumin should not be compared solely by milligram amount.
  • Compare the actual product formulation with the research intervention rather than comparing only milligrams.

Plant part considerations

  • Confirm the material is the Curcuma longa rhizome and distinguish whole turmeric from curcuminoid preparations.

Extract considerations

  • Identify the extract and extraction approach where disclosed.
  • Distinguish turmeric extract from concentrated curcuminoid or curcumin preparations.

Standardization considerations

  • Record stated curcuminoid standardization where available.
  • Do not infer clinical equivalence from standardization alone.

Evaluation

How to evaluate a supplement

What to check

  • Curcuma longa identity
  • Whole turmeric versus extract versus curcuminoid or curcumin preparation
  • Curcuminoid content
  • Standardization
  • Bioavailability technology
  • Piperine or other absorption modifiers
  • Additional ingredients
  • Serving size
  • Identity, contaminant and batch testing
  • Label transparency

Serving considerations

  • Compare the actual preparation and serving with the research intervention.
  • A larger milligram number does not necessarily mean a stronger or better product.

Testing considerations

  • Look for identity and contaminant testing.
  • Look for batch or lot traceability.

Label transparency

  • The product should disclose enough information to identify whether it is whole turmeric, a turmeric extract, concentrated curcuminoids, or a bioavailability-enhanced curcumin formulation.

Categories

Related categories

Explore the HerbParlor categories this herb is grouped under.

Ingredients

Related ingredients

Recipes

Related recipes

verifiedLast reviewed 2026-09-15

Sections reviewed

overviewbotanicaltraditionalContextpreparationsresearchevidencesafetyproductEvaluationrelationships

Replaced the legacy Turmeric placeholder evidence summary with a structured botanical, preparation, research, evidence, safety and product-evaluation profile grounded in current authoritative and clinical sources.

This profile is provided for educational purposes only and is not medical advice. Traditional context and research summaries are distinguished from claims, and nothing here is a treatment recommendation. Always consult a qualified healthcare professional before using any herb, especially if you are pregnant, nursing, take medication, or have a medical condition.